nicotinamide mononucleotide has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badalzadeh, R; Chodari, L; Ghaffari, S; Høilund-Carlsen, PF; Mokhtari, B; Yasami, M | 1 |
| Imai, S; Mills, KF; Yoon, MJ; Yoshino, J | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Melatonin/nicotinamide mononucleotide/ubiquinol: a cocktail providing superior cardioprotection against ischemia/reperfusion injury in a common co-morbidities modelled rat.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Infarction; Ischemia; Male; Melatonin; Morbidity; Myocardial Ischemia; Myocardial Reperfusion Injury; Nicotinamide Mononucleotide; Rats; Rats, Wistar | 2023 |
Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.
Topics: Aging; Animals; Circadian Rhythm; Cytokines; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Glucose; Hypoglycemic Agents; Insulin; Lipid Metabolism; Mice; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Sirtuin 1 | 2011 |